Adjunctive Everolimus Treatment of Refractory Epilepsy
Clinical trial NCT05613166 · UNKNOWN
Trial details
- NCT number
- NCT05613166
- Sponsor
- National Institute on Drug Dependence, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2023-01-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.